Piramal Pharma Ltd
Piramal Pharma's GHG Emissions Data Preview
In 2023, Piramal Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Piramal Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Piramal Pharma's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Piramal Pharma amounted to 124,249 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Piramal Pharma decreased by 8.65%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
Piramal Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Piramal Pharma's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Piramal Pharma were 43,277 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Piramal Pharma reduced its Scope 1 emissions over time?
Since 2021, Piramal Pharma's Scope 1 emissions have increased by 4.54%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Piramal Pharma's Scope 1 emissions decreased by 6.43%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
What are Piramal Pharma's Scope 2 emissions?
In 2023, Piramal Pharma reported Scope 2 greenhouse gas (GHG) emissions of 80,972 tCOâ‚‚e without specifying the calculation method.
Has Piramal Pharma reduced its Scope 2 emissions over time?
Since 2021, Piramal Pharma's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Piramal Pharma 's emissions have plateaued with no significant change in its energy consumption footprint.
Compared to the previous year (2022), Piramal Pharma's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Piramal Pharma 's emissions have plateaued with no significant change in its energy consumption footprint.
What methodology does Piramal Pharma use for Scope 2 reporting?
In 2023, Piramal Pharma reported its Scope 2 emissions using an unspecified methodology.
Piramal Pharma's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)